NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/05/2023
Back to search
Official data from USPTO
IDEAL IMMUNOGLOBULIN, DIAGNOSIS, EVALUATION, AND KEY LEARNINGS PATIENT REGISTRY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
01/05/2023
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
12/09/2010
Registration date
08/21/2012
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/05/2023
Last transaction
01/05/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
12/15/2009
First use in commerce
12/15/2009
Drawing code
3
Owner type
16
Owner location
Woonsocket, RI, US
Examiner
WELLS, KELLEY L
Law office
L50
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the stylized words "IDEaL Immunoglobulin, Diagnosis, Evaluation, and key Learnings Patient Registry" and an icon consisting of two rectangular pillars with oval disks angled above each. This icon is located to the left of the stylized words and depicts a highly stylized representation of a molecule.
Holders and representatives
Holders
Coram LLC
Coram, Inc.
Representatives
Erich G. Rhynhart CVS Pharmacy, Inc.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and scientific researchstudies relating to patients treated with immunoglobulin; scientific study and research in the field of immunoglobulin; providing an on-line searchable database featuring medical and scientific researchincluding clinical trialsconcerning immunoglobulin patients and therapies; providing information on medical and scientific research concerning immunoglobulin patients and therapies; providing medical and scientific research information in the field of clinical trials; providing medical research and scientific research information in the field of immunoglobulin clinical trials
Publications
History of USPTO decisions and trademark events.
47 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/05/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/05/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/05/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
06/16/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/21/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/13/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/13/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/13/2018
E815
TEAS SECTION 8 & 15 RECEIVED
08/06/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/21/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/26/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/26/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/14/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/10/2014
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/10/2014
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/05/2014
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/15/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
08/21/2012
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/11/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/05/2012
PUBO
PUBLISHED FOR OPPOSITION
06/05/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/16/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/02/2012
ALIE
ASSIGNED TO LIE
05/01/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/13/2012
EXPI
EX PARTE APPEAL-INSTITUTED
04/09/2012
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
04/09/2012
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
04/09/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/02/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/31/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2012
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/31/2012
DOCK
ASSIGNED TO EXAMINER
12/08/2011
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/07/2011
GNFR
FINAL REFUSAL E-MAILED
10/07/2011
CNFR
FINAL REFUSAL WRITTEN
10/07/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/17/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/16/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/16/2011
GNRT
NON-FINAL ACTION E-MAILED
03/16/2011
CNRT
NON-FINAL ACTION WRITTEN
03/16/2011
DOCK
ASSIGNED TO EXAMINER
03/14/2011
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
12/15/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/14/2010
NWAP
NEW APPLICATION ENTERED
12/13/2010
Continuous trademark protection
Get notified about every new filing that threatens IDEAL IMMUNOGLOBULIN, DIAGNOSIS, EVALUATION, AND KEY LEARNINGS PATIENT REGISTRY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.